Ayyavoo V - Search Results

1

Development of genetic vaccines for pathogenic genes: construction of attenuated vif DNA immunization cassettes.

Ayyavoo V, Nagashunmugam T, Boyer J, Mahalingam S, Fernandes LS, Le P, Lin J, Nguyen C, Chattargoon M, Goedert JJ, Friedman H, Weiner DB. Ayyavoo V, et al. AIDS. 1997 Oct;11(12):1433-44. doi: 10.1097/00002030-199712000-00007. AIDS. 1997. PMID: 9342065

2

Development of a multicomponent candidate vaccine for HIV-1.

Kim JJ, Ayyavoo V, Bagarazzi ML, Chattergoon M, Boyer JD, Wang B, Weiner DB. Kim JJ, et al. Among authors: ayyavoo v. Vaccine. 1997 Jun;15(8):879-83. doi: 10.1016/s0264-410x(96)00260-5. Vaccine. 1997. PMID: 9234538 Free article.

3

Construction of attenuated HIV-1 accessory gene immunization cassettes.

Ayyavoo V, Nagashunmugam T, Phung MT, Buckner C, Kudckodkar S, Le P, Reddy PJ, Santiago L, Patel M, Tea L, Weiner DB. Ayyavoo V, et al. Vaccine. 1998 Nov;16(19):1872-9. doi: 10.1016/s0264-410x(98)00172-8. Vaccine. 1998. PMID: 9795395 Free article.

4

Immunogenicity of a novel DNA vaccine cassette expressing multiple human immunodeficiency virus (HIV-1) accessory genes.

Ayyavoo V, Kudchodkar S, Ramanathan MP, Le P, Muthumani K, Megalai NM, Dentchev T, Santiago-Barrios L, Mrinalini C, Weiner DB. Ayyavoo V, et al. AIDS. 2000 Jan 7;14(1):1-9. doi: 10.1097/00002030-200001070-00001. AIDS. 2000. PMID: 10714562

5

Issues for improving multiplasmid DNA vaccines for HIV-1.

Muthumani K, Kudchodkar S, Zhang D, Bagarazzi ML, Kim JJ, Boyer JD, Ayyavoo V, Pavlakis GN, Weiner DB. Muthumani K, et al. Among authors: ayyavoo v. Vaccine. 2002 May 6;20(15):1999-2003. doi: 10.1016/s0264-410x(02)00086-5. Vaccine. 2002. PMID: 11983262 Review.

6

Engineering of DNA vaccines using molecular adjuvant plasmids.

Sin JI, Kim J, Chattergoon M, Ayyavoo V, McCallus D, Ugen KE, Boyer JD, Weiner DB. Sin JI, et al. Among authors: ayyavoo v. Dev Biol (Basel). 2000;104:187-98. Dev Biol (Basel). 2000. PMID: 11713819 Review.

7

Inclusion of Vpr accessory gene in a plasmid vaccine cocktail markedly reduces Nef vaccine effectiveness in vivo resulting in CD4 cell loss and increased viral loads in rhesus macaques.

Muthumani K, Bagarazzi M, Conway D, Hwang DS, Ayyavoo V, Zhang D, Manson K, Kim J, Boyer J, Weiner DB. Muthumani K, et al. Among authors: ayyavoo v. J Med Primatol. 2002 Aug;31(4-5):179-85. doi: 10.1034/j.1600-0684.2002.02004.x. J Med Primatol. 2002. PMID: 12390540

8

DNA inoculation as a novel vaccination method against human retroviruses with rheumatic disease associations.

Ugen KE, Wang B, Ayyavoo V, Agadjanyan M, Boyer J, Li F, Kudchodkar S, Lin J, Merva M, Fernandes L, et al. Ugen KE, et al. Among authors: ayyavoo v. Immunol Res. 1994;13(2-3):154-62. doi: 10.1007/BF02918276. Immunol Res. 1994. PMID: 7775806 Review.

9

Analysis of genetic heterogeneity, antigenicity, and biological characteristics of HIV-1 in a maternal transmitter and nontransmitter patient pair.

Ayyavoo V, Ugen KE, Fernandes LS, Goedert JJ, Rubinstein A, Williams WV, Weiner DB. Ayyavoo V, et al. DNA Cell Biol. 1996 Jul;15(7):571-80. doi: 10.1089/dna.1996.15.571. DNA Cell Biol. 1996. PMID: 8756338

10

In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen.

Kim JJ, Ayyavoo V, Bagarazzi ML, Chattergoon MA, Dang K, Wang B, Boyer JD, Weiner DB. Kim JJ, et al. Among authors: ayyavoo v. J Immunol. 1997 Jan 15;158(2):816-26. J Immunol. 1997. PMID: 8992999

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters